Related Experiment Video
Updated: Jun 29, 2025

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
Metabolic dysfunction-associated fatty liver disease: current therapeutic strategies
Khamis Al Hashmi1, Rosaria Vincenza Giglio2,3, Anca Pantea Stoian4
1Department of Physiology, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman.
Metabolic Associated Fatty Liver Disease (MAFLD) now includes cardiometabolic risk factors. This review explores lifestyle changes and therapies, including nutraceuticals and pharmaceuticals, for managing MAFLD and its related conditions.
Area of Science:
- Hepatology
- Cardiology
- Endocrinology
Background:
- Metabolic Associated Fatty Liver Disease (MAFLD) definition incorporates cardiometabolic criteria, replacing Nonalcoholic Fatty Liver Disease (NAFLD).
- MAFLD emphasizes the bidirectional relationship between hepatic steatosis, Type 2 Diabetes Mellitus (T2DM), and Cardiovascular Disease (CVD).
Purpose of the Study:
- To review current therapeutic strategies for MAFLD treatment and prevention.
- To explore the role of lifestyle modifications, nutraceuticals, and pharmacological agents in managing MAFLD.
Main Methods:
- Literature review of studies on MAFLD, T2DM, CVD, and related therapies.
- Analysis of evidence supporting nutraceuticals (e.g., silymarin, berberine, vitamin E) and pharmaceuticals (e.g., incretins, PCSK9 inhibitors).
Main Results:
- Lifestyle modification (nutrition, physical activity) is the cornerstone of MAFLD therapy.
- Several nutraceuticals show potential benefits for metabolic alterations and hepatic steatosis, but long-term data is needed.
- Pharmacological therapies like incretins and PCSK9 inhibitors offer breakthroughs in preventing and reducing cardiometabolic risk in MAFLD patients.
Conclusions:
- MAFLD management requires a comprehensive approach addressing hepatic, metabolic, and cardiovascular aspects.
- Further research is needed to establish long-term efficacy and safety of various MAFLD therapies.
- Integrated therapeutic strategies are crucial for effective MAFLD treatment and prevention of complications.
Related Concept Videos
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

